Facebook tracking pixel
E87.5
ICD-10-CM
High Potassium

Find information on high potassium (hyperkalemia) diagnosis, including clinical documentation tips, medical coding (ICD-10 CM code E87.5), lab test interpretation, and treatment options. Learn about symptoms of hyperkalemia, serum potassium levels, and best practices for healthcare professionals documenting and coding this electrolyte imbalance. Explore resources for accurate and efficient clinical care related to elevated potassium.

Also known as

Hyperkalemia
Elevated Potassium

Diagnosis Snapshot

Key Facts
  • Definition : Elevated blood potassium level, potentially life-threatening.
  • Clinical Signs : Weakness, nausea, palpitations, irregular heartbeat, muscle pain.
  • Common Settings : Kidney failure, medications, dehydration, tissue injury.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC E87.5 Coding
E87.5

Hyperkalemia

Elevated blood potassium level.

E87.6

Electrolyte imbalance NOS

Unspecified electrolyte disturbances, including possible potassium.

N28.89

Other specified disorders of kidney

Kidney problems that may cause hyperkalemia.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is the high potassium due to an underlying condition?

  • Yes

    Is it due to acute kidney failure?

  • No

    Is it due to medication?

Code Comparison

Related Codes Comparison

When to use each related code

Description
High Potassium (Hyperkalemia)
Pseudohyperkalemia
Mild Hyperkalemia

Documentation Best Practices

Documentation Checklist
  • Document serum potassium level (mmol/L)
  • Specify onset and duration of hyperkalemia
  • Document related symptoms (e.g., EKG changes)
  • List medications impacting potassium levels
  • Document interventions and patient response

Coding and Audit Risks

Common Risks
  • Unspecified Hyperkalemia

    Coding unspecified hyperkalemia (E87.5) without documenting cause or severity risks inaccurate DRG assignment and lost revenue.

  • Drug-Induced Coding

    Failing to code drug-induced hyperkalemia (E87.5, T45.5X5A) when applicable leads to underreporting adverse drug events and inaccurate quality data.

  • Clinical Validation Deficiency

    Lack of clinical validation for hyperkalemia diagnosis (R79.0) can cause coding errors, denials, and compliance issues related to medical necessity.

Mitigation Tips

Best Practices
  • Restrict dietary potassium (ICD-10 E78.0, Z72.3). CDI: Dietary K+ restriction.
  • Review medications impacting K+ levels (e.g., ACE inhibitors, K+-sparing diuretics).
  • Monitor renal function (ICD-10 N18.9). CDI: Evaluate for acute kidney injury.
  • Consider Kayexalate for binding excess potassium. Document indication clearly.
  • Loop diuretics can promote K+ excretion. Monitor electrolytes and hydration.

Clinical Decision Support

Checklist
  • Verify serum potassium >5.0 mEq/L (ICD-10 E87.5)
  • Review medications: ACE inhibitors, ARBs, K+ sparing diuretics
  • Assess renal function (eGFR) and EKG for peaked T waves
  • Evaluate for symptoms: muscle weakness, palpitations

Reimbursement and Quality Metrics

Impact Summary
  • High Potassium (Hyperkalemia) Reimbursement: Diagnosis coding (ICD-10-CM E87.5) accuracy impacts MS-DRG assignment and case-mix index for optimal hospital payment.
  • Coding Accuracy Impact: Correctly specifying acute, chronic, or other related conditions (e.g., drug-induced) ensures appropriate reimbursement levels.
  • Quality Metrics Impact: Hyperkalemia management affects hospital quality reporting tied to patient safety indicators and outcome measures.
  • Hospital Reporting Impact: Accurate documentation and coding influence publicly reported data on hospital performance and clinical outcomes for hyperkalemia.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Frequently Asked Questions

Common Questions and Answers

Q: What are the most effective strategies for managing hyperkalemia in patients with chronic kidney disease stages 4 and 5?

A: Managing hyperkalemia in CKD stages 4 and 5 requires a multifaceted approach. First, identify and address contributing factors such as medications (ACE inhibitors, ARBs, potassium-sparing diuretics), dietary indiscretion, or metabolic acidosis. Initiate dietary potassium restriction counseling and consider prescribing potassium binders like patiromer or sodium zirconium cyclosilicate. For acute or severe hyperkalemia (potassium >6.5 mEq/L or with ECG changes), urgent treatment with intravenous calcium gluconate, insulin with glucose, and/or sodium bicarbonate may be necessary. Close monitoring of potassium levels and renal function is crucial. Explore how integrating regular potassium level monitoring and patient education can improve long-term management of hyperkalemia in advanced CKD. Consider implementing protocols for timely intervention in cases of rising potassium levels.

Q: How can I differentiate between pseudohyperkalemia and true hyperkalemia in a patient with a high potassium lab result?

A: Pseudohyperkalemia, an artificially elevated potassium level, can arise from pre-analytical errors like prolonged tourniquet application, excessive fist clenching during blood draw, hemolysis, or significantly elevated white blood cell or platelet counts. True hyperkalemia reflects an actual increase in serum potassium. To differentiate, repeat the potassium measurement using proper phlebotomy technique, ideally from a freshly drawn sample without a tourniquet. If the repeat result is normal, consider pseudohyperkalemia the likely cause. If hyperkalemia persists, investigate potential causes such as decreased renal excretion, increased potassium intake, or cellular shifts from intracellular to extracellular space. Learn more about the different pre-analytical factors that can contribute to spurious potassium elevations and best practices for accurate blood collection.

Quick Tips

Practical Coding Tips
  • Code hyperkalemia first
  • Document K+ levels, units
  • Specify cause if known
  • Query physician if unclear
  • Check EKG findings

Documentation Templates

Patient presents with hyperkalemia, elevated potassium levels confirmed by serum potassium blood test.  Presenting symptoms include muscle weakness, fatigue, and nausea.  Patient denies chest pain but reports a generalized feeling of malaise.  Electrocardiogram (ECG, EKG) shows peaked T waves, consistent with hyperkalemia diagnosis.  Differential diagnosis considered hypokalemic periodic paralysis, renal failure, and Addison's disease.  Based on lab results and clinical presentation, the diagnosis of hyperkalemia is confirmed.  Treatment plan includes dietary potassium restriction, discontinuation of any contributing medications (e.g., potassium-sparing diuretics, ACE inhibitors), and administration of calcium gluconate for cardiac membrane stabilization.  Patient education provided regarding potassium-rich foods and medication management.  Follow-up appointment scheduled to monitor potassium levels and assess treatment efficacy.  ICD-10 code E87.5, hyperkalemia, is documented for medical billing and coding purposes.  Patient advised to seek immediate medical attention if symptoms worsen or new symptoms develop.
High Potassium - AI-Powered ICD-10 Documentation